187 related articles for article (PubMed ID: 11093363)
1. An assessment of iloperidone for the treatment of schizophrenia.
Jain KK
Expert Opin Investig Drugs; 2000 Dec; 9(12):2935-43. PubMed ID: 11093363
[TBL] [Abstract][Full Text] [Related]
2. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?
Albers LJ; Musenga A; Raggi MA
Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919
[TBL] [Abstract][Full Text] [Related]
3. New atypical antipsychotics for schizophrenia: iloperidone.
Caccia S; Pasina L; Nobili A
Drug Des Devel Ther; 2010 Feb; 4():33-48. PubMed ID: 20368905
[TBL] [Abstract][Full Text] [Related]
4. Iloperidone for the treatment of schizophrenia.
Marino J; Caballero J
Ann Pharmacother; 2010 May; 44(5):863-70. PubMed ID: 20388862
[TBL] [Abstract][Full Text] [Related]
5. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
[TBL] [Abstract][Full Text] [Related]
6. Iloperidone: A new drug for the treatment of schizophrenia.
Arif SA; Mitchell MM
Am J Health Syst Pharm; 2011 Feb; 68(4):301-8. PubMed ID: 21289324
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
8. Iloperidone for schizophrenia.
Rado J; Janicak PG
Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
10. Iloperidone: a new option for the treatment of schizophrenia.
Cutler AJ
Expert Rev Neurother; 2009 Dec; 9(12):1727-41. PubMed ID: 19951132
[TBL] [Abstract][Full Text] [Related]
11. Iloperidone for the treatment of schizophrenia.
Bishop JR; Bishop DL
Drugs Today (Barc); 2010 Aug; 46(8):567-79. PubMed ID: 20830317
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
[TBL] [Abstract][Full Text] [Related]
13. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
Kalkman HO; Subramanian N; Hoyer D
Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
[TBL] [Abstract][Full Text] [Related]
14. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
Potkin SG; Litman RE; Torres R; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
[TBL] [Abstract][Full Text] [Related]
16. ACS chemical neuroscience molecule spotlight on Fanapt.
Hopkins CR
ACS Chem Neurosci; 2010 Jun; 1(6):410. PubMed ID: 22778835
[TBL] [Abstract][Full Text] [Related]
17. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
19. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.
Citrome L
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370
[TBL] [Abstract][Full Text] [Related]
20. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
Bobo WV
Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]